Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Half-Year Report 1 January 2020 – 30 June 2020

Risk Intelligence A/S (“Risk Intelligence” or the “Company") hereby publishes the Half-Year Report for the period January 2020 - June 2020. The report is available on the Company’s website (www.riskintelligence.eu).Due to the impact of COVID-19 specifically from February to mid-June total revenue in 1H 2020 (5,495 TDKK) decreased by 7% compared to 1H 2019 (5,904 TDKK). The satisfactory growth in Q1 2020 (+16%) reduces the Q2 2020 significant negative impact (-34%) on the first half year. Q2 revenue would have been significantly better and subsequently 1H revenue growth would have been

The OPRA™️ Implant System Revitalizes People with Amputation at St.Luke's Medical Center in Denver, Colorado

As the Rocky Mountain and Great Plains Regions' premier medical community for more than 30 years, the Institute for Limb Preservation  at Presbyterian/St. Luke's Medical Center aims to provide a multidisciplinary and integrated approach to amputee treatment and care, with primary research focusing on postoperative functional recovery.The OPRA™️ Implant System has successfully improved the lives of more than 500 amputees in the past 30 years, and this long track record

Employee-elected board members resigned from the board of Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 21 - 19 AUGUST 2020  The following employee-elected board members have today resigned from the board of Dampskibsselskabet NORDEN, as their employment has been transferred to a newly established joint venture which will in the future handle the technical operation of NORDENs tanker fleet as mentioned in the quarterly report for the second quarter 2020: Susanne Fauerskov, Head of Marine PayrollLars Enkegaard Biilmann, Captain The employees of the Company will elect substitute board representatives as soon as possible. Kind regards, Dampskibsselskabet NORDEN

Interim report – second quarter and first half year of 2020

ANNOUNCEMENT NO. 20 - 19 AUGUST 2020   Attached please find the full interim report as PDF file Today, the Board of Directors approved the interim report for the second quarter of 2020. The report contains the following highlights: Results Adjusted Result* for Q2 2020: USD 29 (Q2 2019: USD -12 million) · Assset Management: USD 11 million (USD -3 million) · Dry Operator: USD -4 million (USD -6 million) · Tanker Operator: USD 22 million (USD -3 million) Adjusted Result for H1 2020: USD 58 million (H1 2019: USD -5 million) *”Profit/loss for the period” adjusted

Heimstaden AB: Interim report January-June 2020

Highlights · Rental income for the period was SEK 3,327 million, up 53% compared to the first half of 2019 · Surplus ratio increased to 59 percent (55), driven by higher margins in the Dutch and Czech portfolios as well as lower costs in the existing portfolio · Limited operational and financial impact from Covid-19. Negative impact on rental income of approximately SEK 8 million in the quarter · More than 99 percent of rent collected in the period · Like-for-like rental income growth of 4 percent · Acquisitions in the period amounted to SEK 18,805 million ·

Heimstaden Bostad: Interim report January-June 2020

Highlights · Rental income for the period was SEK 3,308 million, up 68% compared to the first half of 2019 · Surplus ratio increased to 58 percent (55), driven by higher margins in the Dutch and Czech portfolios as well as lower costs in the existing portfolio · Limited operational and financial impact from Covid-19. Negative impact on rental income of approximately SEK 8 million · More than 99 percent of rent collected in the period · Like-for-like rental income growth of 4 percent · Acquisitions in the period amounted to SEK 18,805 million · Unrealised changes in

Ahlstrom-Munksjö joins Ahlström Collective Impact initiative to invest in a better future for children through a new co-operation model with UNICEF Finland

AHLSTROM-MUNKSJÖ OYJ, PRESS RELEASE, August 19, 2020 at 10:00 EEST  Ahlström Collective Impact is a corporate social responsibility initiative by Ahlstrom-Munksjö, Ahlström Capital, Antti Ahlström Perilliset, Destia, Glaston and the Eva Ahlström Foundation. It is committed to creating change by investing in a better future for children in partnerships with UNICEF Finland.    Initiated by the Eva Ahlström Foundation in 2020, Ahlström Collective Impact is a new kind of co-operation model between the partnering companies and UNICEF Finland designed for result in targeted strategic

Invitation to presentation of Sectra’s three-month interim report on September 4

Linköping, Sweden – August 19, 2020 – The international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will publish its three-month interim report for the 2020/2021 fiscal year on September 4, 2020. Sectra invites analysts, investors, and the media to attend a teleconference/audiocast in conjunction with the publication of the report.Publication of three-month interim report: 8:15 a.m. CEST, September 4, 2020Presentation: 10:00 a.m. CEST, September 4, 2020 To participate, follow online at investor.sectra.com/q1report2021 or call one of

Cloetta outsources the manufacturing of nuts to improve its competitiveness

To improve the competitiveness and offering within the nuts segment, Cloetta has decided to close the production in Helsingborg and to outsource the manufacturing to a third-party. The initiative is expected to generate savings of up to SEK 10m on an annual basis and incur a total of approximately SEK 15m in one-off restructuring costs.The factory in Helsingborg is Cloetta’s sole processor of nuts, with brands such as Nutisal and Parrots. Nuts play an important role in Cloetta’s portfolio as they offer alternative snacking and are an important growth segment, with the nuts market expected

Interim Report, January - June 2020

Period April 1 – june 30, 2020 · Net sales of SEK 100.3 m (SEK 101.5 m) · Software revenues of SEK 72.5 m (SEK 68.0 m) · Recurring revenues of SEK 62.2 m (SEK 56.4 m) which corresponds to 62 % (56 %) of net sales. · EBITDA SEK 24.2 m; 24.2 % (SEK 25.0 m; 24.6 %) · EBITDA-adj. SEK 14.7 m; 14.6 % (SEK 15.9 m; 15.7 %) · EBIT SEK 11.8 m; 11.7 % (SEK 11.5 m; 11.3 %) · Net profit SEK 8.9 m; 8.9 % (SEK 8.4 m; 8.3 %) · EPS before dilution SEK 0.17 (SEK 0.16) · Cash flow from operating activities SEK 36.2 m (SEK 6.7 m) Period January 1 – June 30, 2020 · Net sales

BEWiSynbra Group AB (publ) – Announcement of terms of the contemplated private placement and launch of bookbuilding

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the previous stock exchange announcement made by BEWiSynbra Group AB (publ) (“BEWiSynbra”) on 18 August 2020 regarding, inter alia, the contemplated private placement of existing shares in BEWi ASA. Frøya Invest AS (“Frøya”) and Verdane Capital 2019 (D) AB, Verdane Capital 2019 (E) AB and Verdane ETF III SPV K/S, (directly

Odfjell SE appoints first Chief Sustainability Officer

As a part of its ambitious sustainability strategy for the coming years, Odfjell SE introduces a new executive position and appoints Øistein Jensen as the company’s first Chief Sustainability Officer (CSO).Øistein Jensen, currently Chief of Staff, takes on the new role and will lead Odfjell SE’s company-wide work on environmental, social and governance matters (ESG).   “Our appointment of a Chief Sustainability Officer reflects our firm commitment to ESG and the responsibility we take as a global operator. We are pleased that Øistein Jensen has accepted this challenge. Sustainability is

Disclosure notice Everysport Media Group AB (publ.)

Everysport Media Group AB (publ.) has today, August 19[th], received information that Paul Fischbein, Chairman of the Board of Everysport Media Group AB has increased his shareholding of the Company to 5,1% of the shares and votes in the Company.Paul Fischbein, through controlled companies and privately held shares, as of August 19[th], has a total shareholding amounting to 231 505 shares in Everysport Media Group AB (publ.), corresponding to 5,1% of shares and votes in the Company. The increase in the number of shares is related to a purchase transaction on the Spotlight Stock Market

Partner selection ultimately happens in the woman’s reproductive tract

The female reproductive tract has the final say in human mate choice, according to new research from the University of Eastern Finland. Achieving pregnancy has been shown to be more likely between partners who carry dissimilar human leucocyte antigen (HLA) immune genes. Accordingly, humans are expected to choose HLA dissimilar reproductive partners. Earlier studies have demonstrated that HLA dissimilarity preferences are mediated either by body odours or facial preferences. However, it has been unclear whether HLA-based mating preferences could occur after sexual intercourse in the

Endomines’ postpones the disclosure of Half year report H1-2020

Endomines AB, Stock Exchange Release 19 August 2020 at 08:30 CEST Endomines AB (publ) has resolved to postpone the disclosure of the Half year report H1-2020. The half year report was supposed to be published on the 20 of August 2020. The new disclosure date is on the 27 of August 2020. Stockholm on August 19, 2020 Endomines AB (publ) Board of directors For further information, please contact: Marcus Ahlström, Deputy CEO and CFO, +358 50 544 68 14, Marcus.ahlstrom(at)endomines.com The information was submitted for publication, through the agency of the contact persons

Arctic Paper S.A., Q2/H1 2020: Strengthened position on a Corona-affected market

• Q2 consolidated sales revenue was PLN 616.0mn (EUR[1] 139.5mn).• EBITDA in Q2 was PLN 48.0mn (EUR[1] 10.9mn).• EBIT in Q2 was PLN 24.2mn (EUR[1] 5.5mn) and net profit PLN 10.8mn (EUR[1] 2.4mn).• EBIT in H1 was PLN 103.9mn (EUR[1] 23.5mn) and net profit PLN 73.1mn (EUR[1] 16.55mn).• The combination of pulp and paper makes the Group more resilient in challenging times.• The Group maintained a strong liquidity position. Net debt/EBITDA reached 0.83 (as compared to 1.06 for Q2 2019).• While total sales were negatively impacted by the pandemic, the paper segment managed relatively

BioStock: Follicum reaches milestone in hair study

Yesterday, Follicum announced that they have recruited over 50 per cent of the intended patient group for their ongoing phase IIa trial with the topical formulation of the hair growth stimulating candidate FOL-005. Thus, the study is well on its way to keeping the communicated timelines, and results are expected in the spring.Read the full article at biostock.se: https://www.biostock.se/en/follicum-reaches-milestone-in-hair-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Hexagon to transfer CNG LDV to its g-mobility business – establishing Hexagon Purus as a pure e-mobility business

Hexagon Composites announces today the transfer of its Compressed Natural Gas Light Duty Vehicle (CNG LDV) activities from Hexagon Purus, to Hexagon’s gas-mobility (g-mobility) business. This transfer will establish Hexagon Purus as a pure e-mobility business. Post initial COVID-19 disruption, de-carbonization is high up on the global agenda and there is a strong push to limit carbon emissions. This momentum is evidenced by many government responses which have put attention firmly back on climate change, renewable energy and new green technologies. This is creating unprecedented

Asarina Pharma AB (publ) Interim Report Q2 2020 released

Asarina Pharma CEO Peter Nordkild: “The second Quarter 2020 has given us continued proof of the urgent need for new, safe and effective treatments for the devastating conditions that our flagship compound, Sepranolone, targets. Despite disappointing results in our Phase IIb PMDD study at the beginning of the Quarter, which we covered extensively in our Q1 Interim Report, this second Quarter powerfully underlined the unmet need for new, safe, effective treatments for menstrual migraine and Tourette Syndrome.”FINANCIAL HIGHLIGHTS · Decrease in R&D costs after completion of PMDD study ·

OssDsign AB (publ) publishes Q2 2020 interim report

Sales growth during a quarter impacted by Covid-19.The second quarter in figures · Net sales amounted to TSEK 3 905 (3 454). · Loss after taxes amounted to TSEK 22 586 (18 330). · Loss per share was SEK 1,3 (1,3). · Cash flow from current operations was TSEK -15 829 (-13 917).  The first half year in figures ·Net sales amounted to TSEK 11 631 (6 968). · Loss after taxes amounted to TSEK 40 898 (35 670). · Loss per share was SEK 2,3 (2,7). · Cash flow from current operations was TSEK -37 962 (-36 464).  Important events during the second quarter

TC TECH Sweden AB (publ) publishes its interim report as of June 30th, 2020

TC TECH has today published its interim report for the period January 1 to June 30, 2020.Net sales amounted to 0 (4 254) TSEK in the second quarter of 2020. In the same period, net profit/loss totalled -5 250 (-6 838) TSEK. Cash flow from operating activities was -2 987 (-9 270) TSEK in the second quarter of 2020.  Net sales amounted to 105 (5 118) TSEK in the first half of 2020, while net profit/loss totalled -12 657 (-15 372) TSEK. Cash flow from operating activities was -10 328 (-15 947) TSEK in the period from 1 January to 30 June 2020.  Developments in the second quarter of 2020

Sedana Medical signs distribution agreement in Australia and New Zeeland

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has signed a distribution agreement for sales in Australia and New Zeeland with the distributor Device Technologies. As the AnaConDa already has market approval in both markets, sales can start immediately. Sedana Medical estimates that the annual market potential in these two markets to around SEK 300 million.Device Technologies has over 850 employees supplying Australia and New Zealand with leading edge globally trusted brands within both medical devices and pharmaceuticals. “Device Technologies is a

FSN CAPITAL SHAREHOLDERS HAVE SOLD THEIR SHARES IN BHG GROUP AB (PUBL)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Press release Stockholm, 19 August 2020, 08:00 CEST FSN CAPITAL SHAREHOLDERS HAVE SOLD THEIR SHARES IN BHG GROUP AB (PUBL) Builder IV Holdings Limited, Builder V Holdings Limited and FSN Capital Project Growth GP Limited (together, the “FSN Capital Shareholders”)1 have sold 7,319,041 shares in BHG Group AB (publ) (“BHG”) to Swedish and international institutional

Interim report Q2 2020

QUOTE FROM OSKAR MÜHLBACH, CEO“The strong operational development for Raketech continued during the second quarter of 2020 with several initiatives launched and improved, resulting in a stable product portfolio performance for the quarter. Q2 revenues amounted to 7.0m EUR compared to 5.7m EUR the same quarter previous year, representing a growth of 24.1%. EBITDA margin amounted to 40.2% compared to 51.1% previous year as an expected effect of the Lead Republik revenues having slightly lower margin as well as our efforts within geographical expansion – in line with our strategic goals.”

There are no items matching the current filter
There are no more items matching the current filter
Back to top